HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Talampicillin and probenecid compared with ampicillin and probenecid for the treatment of gonococcal urethritis in men.

Abstract
Two hundred and ten men suffering from uncomplicated gonococcal urethritis were treated with one of two treatment schedules. Of 109 patients treated with 3 g ampicillin and 2 g probenecid (group A) there were two recurrences in the first week after treatment and none in the second week. Of 101 patients treated with 1.5 g talampicillin and 2 g probenecid (group B), there were three recurrences in the first week and none in the second week. Both antibiotics were well tolerated, but one patient vomited two hours after taking talampicillin. The sensitivity pattern of Neisseria gonorrhoeae to penicillin at The London Hospital has shown an increase in the proportion of more sensitive strains during the last three years. Talampicillin given in a single dose with probenecid is satisfactory in the treatment of acute gonococcal urethritis but, apart from the smaller dosage, it does not offer any advantage over ampicillin with probenecid.
AuthorsS Al-Egaily, E M Dunlop, P Rodin, A D Seth
JournalThe British journal of venereal diseases (Br J Vener Dis) Vol. 54 Issue 4 Pg. 243-6 (Aug 1978) ISSN: 0007-134X [Print] England
PMID678956 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Talampicillin
  • Ampicillin
  • Probenecid
Topics
  • Adolescent
  • Adult
  • Ampicillin (therapeutic use)
  • Gonorrhea (drug therapy)
  • Humans
  • Male
  • Microbial Sensitivity Tests
  • Middle Aged
  • Probenecid (therapeutic use)
  • Talampicillin (therapeutic use)
  • Urethritis (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: